HuGE Literature Finder
Records
1
-
5
| Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs). Lung cancer (Amsterdam, Netherlands) 2017 Feb 104 24-30. Tiseo Marcello, Damato Angela, Longo Lucia, Barbieri Fausto, Bertolini Federica, Stefani Alessandro, Migaldi Mario, Gnetti Letizia, Camisa Roberta, Bordi Paola, Buti Sebastiano, Rossi Giul |
| Mutational analysis of PI3K/AKT and RAS/RAF pathway activation in malignant salivary gland tumours with a new mutation of PIK3CA. International journal of oral and maxillofacial surgery 2016 Jan . Shalmon B, Drendel M, Wolf M, Hirshberg A, Cohen |
| Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations. Clinical chemistry 2014 Jul 60 (7): 1004-11. Liu Xiaoying, Mody Kabir, de Abreu Francine B, Pipas J Marc, Peterson Jason D, Gallagher Torrey L, Suriawinata Arief A, Ripple Gregory H, Hourdequin Kathryn C, Smith Kerrington D, Barth Richard J, Colacchio Thomas A, Tsapakos Michael J, Zaki Bassem I, Gardner Timothy B, Gordon Stuart R, Amos Christopher I, Wells Wendy A, Tsongalis Gregory |
| Mutations in FGFR3 and PIK3CA, singly or combined with RAS and AKT1, are associated with AKT but not with MAPK pathway activation in urothelial bladder cancer. Human pathology 2012 Oct 43 (10): 1573-82. Juanpere Nuria, Agell Laia, Lorenzo Marta, de Muga Silvia, López-Vilaró Laura, Murillo Raquel, Mojal Sergi, Serrano Sergio, Lorente José A, Lloreta Josep, Hernández Silv |
| Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma-rationale for comprehensive mutation profiling. Molecular cancer therapeutics 2012 Feb 11 (2): 485-91. Chaft Jamie E, Arcila Maria E, Paik Paul K, Lau Christopher, Riely Gregory J, Pietanza M Catherine, Zakowski Maureen F, Rusch Valerie, Sima Camelia S, Ladanyi Marc, Kris Mark |
- Page last reviewed:Jul 25, 2022
- Page last updated:Jan 27, 2023
- Content source: